185 related articles for article (PubMed ID: 35637248)
21. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
[TBL] [Abstract][Full Text] [Related]
22. Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma.
Jiang X; Zhang W; Li L; Xie S
Pathol Oncol Res; 2021; 27():1609985. PubMed ID: 34737677
[TBL] [Abstract][Full Text] [Related]
23. Identifying 13 Hub Genes Associated with Progression and Prognosis of Hepatocellular Carcinoma with Weighted Gene Co-Expression Network Analysis.
Liu Y; Cheng R; Chang Q; Wu Y; Liu C; Liu Y; Wu X; Cheng L; Hu L; Yin J
Crit Rev Eukaryot Gene Expr; 2021; 31(4):59-69. PubMed ID: 34587436
[TBL] [Abstract][Full Text] [Related]
24.
Sun Y; Zhang Z
Genet Test Mol Biomarkers; 2020 May; 24(5):296-308. PubMed ID: 32384023
[No Abstract] [Full Text] [Related]
25. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
27. Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis.
Hua S; Ji Z; Quan Y; Zhan M; Wang H; Li W; Li Y; He X; Lu L
Aging (Albany NY); 2020 Mar; 12(6):5439-5468. PubMed ID: 32213663
[TBL] [Abstract][Full Text] [Related]
28. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
Hou Y; Zhang G
Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
[TBL] [Abstract][Full Text] [Related]
29. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
30. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
Wu M; Jiang L
Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
[TBL] [Abstract][Full Text] [Related]
31. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma.
Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q
Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
33. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
34. Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma.
Li C; Xu J
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32046048
[TBL] [Abstract][Full Text] [Related]
35. Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis.
Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
Medicine (Baltimore); 2021 Jan; 100(2):e24172. PubMed ID: 33466191
[TBL] [Abstract][Full Text] [Related]
36. Association analysis of hepatocellular carcinoma-related hub proteins and hub genes.
Zhang X; Zhang B; Zhang Y; Zhang F
Proteomics Clin Appl; 2023 Sep; 17(5):e2200090. PubMed ID: 37050894
[TBL] [Abstract][Full Text] [Related]
37. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
Zhang Y; Tang Y; Guo C; Li G
Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
[TBL] [Abstract][Full Text] [Related]
38. Identification of Key Functional Modules and Immunomodulatory Regulators of Hepatocellular Carcinoma.
Luo D; Zhang X; Li XK; Chen G
J Immunol Res; 2021; 2021():1801873. PubMed ID: 34423049
[TBL] [Abstract][Full Text] [Related]
39. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
40. Identification of G6PC as a potential prognostic biomarker in hepatocellular carcinoma based on bioinformatics analysis.
Tian L; Liao Y
Medicine (Baltimore); 2022 Aug; 101(33):e29548. PubMed ID: 35984176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]